2 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2222066/exelixis-exel-tops-q4-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2222066
Feb 06, 2024 - Exelixis (EXEL) delivered earnings and revenue surprises of 6.45% and 0.33%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:3937159372876389236
0
https://www.zacks.com/stock/news/2227081/are-you-looking-for-a-top-momentum-pick-why-eyepoint-pharmaceuticals-eypt-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2227081
Feb 15, 2024 - Does EyePoint Pharmaceuticals (EYPT) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-5899218392320992319
0